David Levy

Contributor   in
AI and Big Data  

Dave Levy is Global Product Director at Scitara Corporation. With experience in strategic domestic and international software development as well as in project management and sales within the life science marketplace, Dave is responsible for leading the global product innovation strategy. Over his 30 year career, Dave has held roles at leading life science software companies including NuGenesis Technologies and CambridgeSoft Inc, and most recently at PerkinElmer where he was responsible for leading key strategic accounts.

tags:   Artificial Intelligence     Big Data    

Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.

Posts by this author

Accelerating the Pace of Science Discovery Through Digital Transformation

   434
Accelerating the Pace of Science Discovery Through Digital Transformation

The future of the connected world is not just about the newest frontier technologies, such as high-band 5G. It will be defined by the expansion and evolution of existing advanced connectivity technologies – and the new architecture of connectivity will feature cloud and edge computing that is growing more powerful and more affordable.  The connectivity ecosystem will be populated with more technologies, services, and providers than ever before.

Nowhere is this more visible than in the life sciences industry. The International Data Corporation (IDC) estimates that approx. 270 GB of healthcare and life science data will be created for every person in the world in 2020.   However, the true potential value of these data goes largely untapped.  A recent McKinsey report states that, “Technology has not delivered the kind of progress that many expected and compared to other domains healthcare has lagged in digitizing.”